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The computational mining of genomes has become an important part in the discovery of novel natural
products as drug leads. Thousands of bacterial genome sequences are publically available these days
containing an even larger number and diversity of secondary metabolite gene clusters that await linkage to
their encoded natural products. With the development of high-throughput sequencing methods and the
wealth of DNA data available, a variety of genome mining methods and tools have been developed to
guide discovery and characterisation of these compounds. This article reviews the development of these
computational approaches during the last decade and shows how the revolution of next generation
sequencing methods has led to an evolution of various genome mining approaches, techniques and tools.
After a short introduction and brief overview of important milestones, this article will focus on the diﬀerent
approaches of mining genomes for secondary metabolites, from detecting biosynthetic genes to resistance
based methods and “evo-mining” strategies including a short evaluation of the impact of the development
of genome mining methods and tools on the ﬁeld of natural products and microbial ecology.
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1. Introduction
The fast development of genome sequencing methods revolu-
tionized almost every aspect of biology including natural
product research. We have come a long way during the last three
decades from the identication and manipulation of the rst
secondary metabolite genes to whole genome sequencing of
thousands of bacterial genomes and metagenomes for a fast
and automated discovery of promising new natural products
and their role in the environment. With the wealth of genetic
data available these days, there is no shortage of secondary
metabolite gene clusters anymore; the challenge is now to
eﬀectively mine the data, connect whenever possible detected
Biosynthetic Gene Clusters (BGC) to the vast amount of already
known molecules and predict the ones that encode the most
promising compounds. Plenty of tools are available to enable
researchers to computationally mine genetic data and connect
them to known secondary metabolites, and plenty of reviews are
available that describe those tools and their applications. This
review is focused on the development of genome mining
methods over the last 10 years and the various strategies to
detect and prioritize secondary metabolite gene clusters (Fig. 1).
Rather than presenting extensive examples we focus on the
rapid evolution of genome mining approaches and strategies
and give some examples of when and how they were used for
compound discovery, and which directions and challenges are
remaining in the near future.
aInterfaculty Institute for Microbiology and Infection Medicine Tu¨bingen (IMIT),
Microbiology and Biotechnology, University of Tuebingen, Germany. E-mail: nadine.
ziemert@uni-tuebingen.de
bGerman Centre for Infection Research (DZIF), Partner Site Tu¨bingen, Germany
cNovo Nordisk Foundation Center for Biosustainability, Technical University of
Denmark, Hørsholm, Denmark. E-mail: tiwe@biosustain.dtu.dk
Cite this:Nat. Prod. Rep., 2016, 33, 988
Received 29th February 2016
DOI: 10.1039/c6np00025h
www.rsc.org/npr
988 | Nat. Prod. Rep., 2016, 33, 988–1005 This journal is © The Royal Society of Chemistry 2016
Natural Product
Reports
REVIEW
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
8 
Ju
ne
 2
01
6.
 D
ow
nl
oa
de
d 
on
 1
0/
08
/2
01
6 
14
:4
5:
06
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e. View Article Online
View Journal  | View Issue
2. A short history of genome mining
Drug discovery eﬀorts have traditionally been based on bioac-
tivity screening eﬀorts of natural sources such as plants, fungi
or bacteria. Bioactive isolated chemical structures, so called
natural products or derivatives of those have been used as drug
leads for new antibiotics, anticancer agents or immunothera-
peutics.1,2 Ignited by the discovery of penicillin and strepto-
mycin, the golden age of antibiotics began and researchers
discovered microbial secondary metabolites as an important
source for new antibacterial compounds. Today, natural prod-
ucts remain the main source for new therapeutic agents. The
genus Streptomyces has especially been chemically exploited for
decades in search for new drugs.3
With the establishment of Streptomyces genetics and the
discovery of the rst biosynthetic genes in the 70s and 80s,
researchers started to understand the biosynthetic logic and
genetic basis for the production of these compounds.4–8 Using
classical genetics or reverse genetics approaches, it was possible
to map and connect many biosynthetic gene clusters to known
molecules.9–12
Beginning with the new millennium and the full genome
sequences of two well studied natural product producing
strains Streptomyces coelicolor13 and Streptomyces avermitilis14
scientist noticed the unexplored potential hidden in bacterial
genomes. A Streptomyces genome contains on average about 30
secondary metabolite gene clusters and only two or three were
known at the time.
At this time the classical idea of genome mining was born:
predicting and isolating natural products based on genetic
information without a structure at hand. Inspired by the
observation that even well studied strains contain the genetic
potential to synthesize many more compounds than detected
analytically, the genome mining concept was expanded to other
microbes where genome information became available, such as
cyanobacteria,39,40 myxobacteria,41–43 and anaerobes.44,45 Nowa-
days, thousands of bacterial genomes have become available,
whole culture collections are currently being sequenced, and
new technologies like single cell genomics and metagenomics
generate massive data to be analyzed.
The current largest collection of automatically mined gene
clusters is the “Atlas of Biosynthetic gene Clusters”, a component
of the “Integrated Microbial Genomes” Platform of the Joint
Genome Institute (JGI IMG-ABC).46 As of February 2016, IMG-ABC
contains entries for more than 960 000 putative gene clusters
identied in JGI's huge genome and metagenome datasets and
public databases. However, only a very small fraction of these
predicted BGCs are characterized and their products described.
In a recent community eﬀort within the “Minimum Information
for Biosynthetic Gene clusters” (MIBiG) standardization initiative
a manual re-annotation of1300 BGCs has been carried out now
providing a highly curated reference dataset.47
3. Classical genome mining: search
for enzymes involved in the
biosynthesis of secondary metabolites
Mining for enzymes, or more precisely genes encoding enzymes
putatively involved in secondary metabolite biosynthesis of
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interest is the most “classical” variant of genome mining.
Although the diversity of secondary metabolites is huge, the
biosynthetic principles and thus the biosynthetic machineries for
many of these compounds are oen strikingly conserved. This is
reected in the high amino acid sequence similarity of many of
the core biosynthetic enzymes. Examples for classes of secondary
metabolites using such conserved machineries are polyketides
(PK), biosynthesized by polyketide synthases (PKS), non-riboso-
mally synthesized peptides (NRP), produced by non-ribosomal
peptide synthetases (NRPS), ribosomally and post-translationally
modied peptides (RiPPs), aminoglycosides, and many more.
Even before large-scale genome sequence data were avail-
able, this sequence conservation was used in reverse genetics
approaches to screen genetic libraries of producers for the
presence of core biosynthetic genes.11 Conserved genes of
characterized pathways (or fragments, e.g., PKS or NRPS
domains) were labeled and used as probes in Southern
hybridization experiments. Alternatively, primers were deduced
from highly conserved motifs of these genes and used for PCR
screening approaches. With improved quality and throughput
of sequencing and the massive decrease of costs, many of these
approaches are currently carried out in silico instead of
involving tedious generation of libraries and experimental
screening. But the general principle behind the in silico mining
is the same for reverse genetics: one or multiple sequences
encoding “reference” enzymes are used as seed sequences to
identify homologues in the genome sequences of the organisms
of interest. For this task, sequence based comparison soware,
like BLAST48 or DIAMOND49 or prole-based tools like HMMer50
are usually used. If the structure of the compound of interest is
already known and a hypothetical biosynthetic route can be
predicted, this approach oen leads to an easy identication of
the responsible biosynthetic gene cluster, as demonstrated for
many pathways, for example: teixobactin,51 cypemycin,52
microbisporicin,53 ristomycin,54 microcyclamide,55 micro-
viridin,56 poly(L-diaminopropionic acid),57 and many more. In
the following sections, we are focusing onmetabolites, in which
the gene cluster was used as the starting point and the
compound was not described before.
While mining for genes encoding conserved biosynthetic
enzymes can, in principle, be easily done manually with BLAST
or HMMer, integrated tools and databases were developed that
greatly expedite this approach. To our best knowledge, the rst
reported tool for automated cluster mining was DECEIPHER®,
a proprietary pipeline and database developed around 2001 by
the former company Ecopia Biosciences Inc.19 In the following
years additional tools were developed and became freely avail-
able including BAGEL,58 CLUSEAN59 and antiSMASH.28 To
provide a comprehensive overview on such soware and data-
bases, the “The Secondary Metabolite Bioinformatics Portal”
was recently launched at http://www.secondarymetabolites.org.
The community-driven website provides a regularly updated
and maintained catalogue of available secondary metabolism
specialized soware and databases and direct links to the
Fig. 1 Evolution of genome mining. Overview about approaches and strategies to mine microbial genomes for novel secondary metabolites
including selected developments in methods: A;4–8 B;15 C;9–12 D;16–18 E,19 F;20 G;21,22 H;23,24 I;25 J;26 K;27,28 L;29,30 M;31 N;32 O;33 P;34 Q;35 R;36 S;27,37 T.38
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Table 1 Examples of novel compounds identiﬁed by mining for core biosynthetic enzymes. Only examples where the BGC directed the
identiﬁcation of the novel metabolites are included
Compound name Gene cluster ID (MIBiG)/Genbank Means of identication Ref.
Type I polyketides
Asperfuranone BGC0000022 Search for PKS genes in A. nidulans whole genome sequence 158
Stambomycins BGC0000151 Search for modular PKS genes in S. ambofaciens 83
Salinilactam BGC0000142 Search for PKS/NRPS domain sequences
(and other secondary metabolite biosynthesis related genes)
in Salinispora tropica CNB-440
85
ECO-02301 BGC0000052 Genome scanning for PKS genes25 80
trans-AT polyketides
Rhizopodin BGC0001111 Search for PKS/NRPS genes in S. aurantiaca
Sg a15 using pipeline96
91
Type II polyketides
Hexaricins Genbank: KT713752 Search for type II gene cluster with antiSMASH 2 (ref. 77) 93
Type III polyketides
Isogermicidin Genbank: AL645882 Analysis of genes encoding type III PKS of S. coelicolor A3(2) 159
Gene: SCO7221
NRPS
Aureusimines BGC0000308 Search for conserved NRPS genes in S. aureus and other
Staphylococcus strains
105
Coelichelin BGC0000325 Search for NRPS genes in S. coelicolor M145 106
Poeamide BGC0001208 Search for NRPS genes in Pseudomonas poae RE*1-1-14 160
Orfamide BGC0000399 Search for NRPS genes in P. uorescens Pf-5 26
Viscosin-family lipopeptide Genbank: AM181176 Search for NRPS genes encoding cyclic lipopeptides 161
Locus: PFLU_2552, 2553, 4007
S. peucetius siderophores Not publicly available Search for NRPS genes, analysis with NRPS–PKS162 163
Thanapeptin Genbank: CBLV010000330 Search for NRPS with PKS/NRPS predictor,96 NP.searcher70
and antiSMASH28
164
Locus: BN844_0667-0664
Hybrid PKS–NRPS
Isoavipucine/
dihydroisoavipucine
BGC0001122 Identication of the hybrid PKS/NRPS gene with SMURF165 166
Aspyridones BGC0000959 Search for hybrid PKS/NRPS genes 167
Pyranonigirin E BGC0001124 Search for hybrid PKS/NRPS genes; comparison with
pynA of A. niger CBS 513.88
168
Haliamide RefSeq: NC_013440 Search for hybrid PKS/NRPS genes with antiSMASH28 169
Locus: HOCH_RS34665-03960
Carlosic acid,
carlosic acid methyl ester
Genbank: ACJE01000021 Search for hybrid PKS/NRPS genes 170
Locus: ASPNIDRAFT_176722
Agglomerin F Genbank: ACJE01000021 Search for hybrid PKS/NRPS genes 170
Locus: ASPNIDRAFT_176722
Mutanobactin Genbank: AE014133 Search for PKS and NRPS genes, analysis with NRPS–PKS162 171 and 172
Locus: SMU_1334-1349
Clarepoxcin A–E BGC0001203 Search for specic KS domain responsible for
synthesizing the epoxyketone warhead173 with eSNAPD37
132
Landepoxcin A/B BGC0001202 Search for specic KS domain responsible for
synthesizing the epoxyketone warhead173 with eSNAPD37
132
RiPPs: lanthipeptides
Venezuelin BGC0000563 Search for genes encoding enzymes with N-terminal
Ser/Thr kinase and C-terminal LanC-type domain
109
Streptocollin BGC0001226 Search for lanthipeptide gene clusters
using antiSMASH 3 (ref. 78)
114
Informatipeptin BGC0000518 Combination of automated genome
mining for RiPPs and mass spectrometric
analysis using RiPPquest116
116
RiPPs: lasso peptides
Capistruin BGC0000572 Search for homologues of microcin J25
biosynthetic genes mcjBCD
121
This journal is © The Royal Society of Chemistry 2016 Nat. Prod. Rep., 2016, 33, 988–1005 | 991
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respective tools and websites.60 As there have been multiple
recent publications reviewing these tools,60–69 here we focus
primarily on the application aspects. Several tools exist focusing
on specic classes of secondary metabolite biosynthetic path-
ways, mostly PKS and/or NRPS70–74 or RiPPs.58,75,76 All these tools
screen genomic data using proles of known and highly
conserved biosynthetic enzymes (e.g., PKS domains) and
evaluate the results using pre-dened manually curated rules.
The most comprehensive platform to perform such analyses
currently is antiSMASH.28,77,78 In the current version 3.04, anti-
SMASH can identify 44 diﬀerent gene cluster types based on hits
against a library of enzymes/protein domains commonly
observed in secondary metabolite biosynthetic pathways.
3.1 Mining for genes encoding core-biosynthetic enzymes
In the following section, several examples – from the beginning
of genome mining, where most sequence analysis steps had to
be carried out manually – until the present, where compre-
hensive bioinformatic soware packages aid the scientists to
identify novel compounds, are discussed for important families
of bioactive secondary metabolites. A more extensive list of
compounds, where genome mining has directly led to the
identication of the metabolites, is included in Table 1.
3.2 Polyketides
Even before whole genome sequencing became a routine
endeavor, genomics guided approaches were used to identify
novel biosynthetic pathways and newmolecules. One of the rst
approaches was published in 2003, when researchers of the
company Ecopia Biosciences Inc. reported the identication of
11 new enediyne BGCs.25 Enediynes are interesting drug
candidates as their high cytotoxicity makes them promising
tools for antibody–drug conjugates to treat cancer.79 As it was
not aﬀordable at that time to simply sequence whole genomes
of the studied actinomycetes, Zazopoulos et al. generated
plasmid libraries of the producers. By Sanger sequencing of
1000 plasmids per library, they were able to generate 700 bp
long “sequence tags” covering the whole genome. The tags then
were compared to sequences of genes involved in warhead
formation of enediyne BGCs that were already known using
Ecopia's DECIPHER® tool and database. Using this strategy, it
was possible to identify 8 out of 50 strains that contain BGCs
encoding enediyne biosynthesis pathways. Although no
analytical proof of enediyne formation was provided in the
original work, results of prophage induction assays indeed
indicated that all of these strains have the potential to produce
DNA damaging agents (as the enediynes are).25 A similar
Table 1 (Contd. )
Compound name Gene cluster ID (MIBiG)/Genbank Means of identication Ref.
Caulosegnins BGC0000574 Search for homologues of lasso peptide
biosynthetic enzymes (B-/C-proteins)
174
Astexin-1 BGC0000570 Search for conserved patterns in lasso peptide
precursor peptide using MEME175/MAST176
177
Burhizin BGC0000571 Search for homologues of lasso peptide
biosynthetic enzymes (B-/C-proteins)
178
Caulonodins BGC0000573 Search for homologues of lasso peptide
biosynthetic enzymes (B-/C-proteins)
178
Rubrivinodin BGC0000576 Search for homologues of lasso peptide
biosynthetic enzymes (B-/C-proteins)
178
Sphingonodins BGC0000577 Search for homologues of lasso peptide
biosynthetic enzymes (B-/C-proteins)
178
Xanthomonins BGC0000580 Search for homologues of lasso peptide
biosynthetic enzymes (B-/C-proteins)
179
Chaxapeptin BGC0001307 Search for homologues of B-protein LarB
(lariatin biosynthesis)
180
RiPPs: cyanobactins
Microcyclamide PCC7806A/B BGC0000474 Search for homologues of cyanobactin clusters in
M. aeruginosa PCC7806
55
Aeruginosamide BGC0000483 Search for cyanobactin gene clusters in cyanobacteria 181
Viridisamide BGC0000471 Search for cyanobactin gene clusters in cyanobacteria 181
Terpenoids/isoprenoids
Cembrane Genbank: AB738084, AB738085 Blast search for homologs of CotB1, a
geranyl-geranyl diphosphate synthase
from cyclooctatin biosynthesis
124
Kolavelools Genbank: ABX04785 Blast search for homologs of Rv3377c
(diterpene cyclase) and Rv3378c (diterpene synthase)
182
Locus: HAUR_2145, HAUR_2146
Stellatic acid Genbank: LC073704 Search for homologs of AcOS, a sesterterpenoid synthase
from ophiobolin F biosynthesis
183
Hydropyrene, hydropyrenol,
and others
Genbank: CM000914 HMM-based search for terpene synthases;127
heterologous expression
126
Locus: SCLAV_p0765
992 | Nat. Prod. Rep., 2016, 33, 988–1005 This journal is © The Royal Society of Chemistry 2016
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strategy was also applied to identify the antifungal agent ECO-
02301, which is biosynthesized via a modular type I PKS
complex.80
With the easy and cheap availability of whole genome
sequence data, many other gene clusters have been identied
and associated with chemical products. One noteworthy
example is the polyketide stambomycin. In the course of the
analysis of the Streptomyces ambofaciens genome, which was
known to code for the congocidine and spiramycin biosynthetic
gene clusters,81,82 a 150 kb gene cluster was identied, which
codes for 25 genes, among them 9 encode type I PKS, making
this one of the largest PKS gene clusters known so far.83 The
analysis with the soware SEARCHPKS84 indicated that the PKS
genes code for 112 enzymatic domains organized in 25 PKS
modules, including a KSQ domain at the starter module and
a TE domain at the last module. Based on the domain organi-
zation, specicity predictions for the AT domains and stereo-
chemistry predictions of KR domains the authors were able to
predict a planar structure of the PK product synthesized by the
PKS – with only one ambiguity as the substrate for the AT of
module 12 (corresponding to the PK-unit C-25–C-26) could not
be predicted. A transcriptional analysis revealed that this gene
cluster was not expressed under normal laboratory growth
conditions. However Laureti et al. were able to activate the
expression by constitutively expressing samR0484, a LuxR-type
regulator. With this engineered strain it was now possible to
isolate the biosynthesis product stambomycin and perform an
NMR-based structure elucidation. The experimentally deter-
mined structure of stambomycin was in very good accordance
with the theoretically predicted product of the PKS. However,
several features were not predicted in silico: the NMR studies
revealed that at position C-26 of the polyketide (corresponding
to the ambiguous AT in module 12) extender units with diverse
sidechains are used (leading to stambomycins A–D) and thus
explains the lack of predictions for this module. In addition, the
sites of macrolactonization, glycosylation and hydroxylations
could not be predicted only based on the sequence analysis.83
However, this work nicely demonstrates the power of the
genome mining approach and that genome sequence data can
be used to predict structures of secondary metabolites.
A nice example where genetic data and structural data go
hand in hand is the polyene macrolactam salinilactam. The sal-
inilactam gene cluster is the biggest gene cluster that was
detected by bioinformatic analysis in the Salinispora tropica CNB-
440 genome.85 The high sequence identity and the repetitive
nature of the variousmodulesmade correct assembly and closure
of the genome problematic. However, based on characteristic UV
chromophores the compound could be detected and initial
structure elucidations suggested a 10-module PKS enzyme
responsible for the biosynthesis of the compound, which facili-
tated assembly and therefore closure of the genome. The subse-
quent bioinformatic analysis of the AT domains on the other
hand facilitated the nal structure elucidation of the compound.
This example aided the discovery of a whole family of macro-
lactams by implementing a “molecules-to-genes-to-molecules”
approach by Schulze et al., who where able to detect the lobosa-
mides and mirilactams by comparative genomic analysis.86
One important group of PKS enzymes are the trans-AT
PKSs.87,88 These owe their name due to the lack of AT domains in
each module; instead they encode one or more AT domains in
trans, usually within each BGC. Genome mining eﬀorts have
shown that this group of enzymes is wide spread in bacteria,
especially in chemically less studied genera.89 trans-AT PKS
systems have evolved independently from cis-AT PKSs90 and
oen include unusual biosynthetic enzymes leading to unique
chemistry. Therefore, trans-AT PKS have been targeted by
genomemining strategies in the past and led to the discovery of
new compounds such as thailandamides,90 rhizopodin91 or
tolytoxin.92 For an in depth review about these systems, we refer
to Helfrich et al.88
Mining for PKS core enzymes is not restricted to cis-AT and
trans-AT modular type I PKS; the technique can also be highly
eﬃciently applied for other types of PK pathways: using the
antiSMASH soware, 20 gene clusters were predicted in the rare
actinomycete Streptosporangium sp. CGMCC 4.7309, among
them the hex-cluster coding for a type II PKS.93 Phylogenetic
analyses indicated that the gene product of hex23, which
encodes the KSb of the type II PKS, can be assigned to a group of
pathways producing pentangular polyphenols. Indeed, Tian
and colleagues were able to detect and elucidate a new family of
polyketides, named hexaricins and experimentally conrmed by
gene knock-out that the gene cluster identied is responsible
for the biosynthesis of the compound.
In the case of type II PKS pathways, the consideration of
phylogenetic data can give more accurate predictions on the
putative products on metagenomic datasets94 (for details, see
Section 5).
3.3 Non-ribosomally synthesized peptides (NRPs)
The high degree of conservation of the core-enzymes involved in
NRP biosynthesis, the good co-linearity of the modular domain
organization of NRPS enzymes with their biosynthetic products,
the possibility to predict substrate specicities, e.g. using soware
like NRPSpredictor,71,72 SEQL-NRPS95 or other A-domain specicity
predictors96–98 have made this family of secondary metabolites
interesting candidates for genome mining approaches.96,99 This
is further supported by the availability of cheminformatic
approaches like MS/MS networking29,100 or iSNAP101 that allow the
automatic mapping of identied and in silico analyzed NRP (and
RiPP) BGCs to mass spectrometric data.73,101–104
Genome mining, for example, led to the identication of
NRP secondary metabolites also from organisms, such as
Staphylococcus aureus,105 which usually are not regarded as
prolic secondary metabolite producers. In the case of the
biosynthesis of the siderophore coelichelin from the model
actinomycete Streptomyces coelicolor M145, genome mining
revealed new biochemical insights about NRPS biochemistry.
The coelichelin pathway, which was identied in the S. coeli-
color genome by searching for NRPS-like genes, codes for a 3-
module NRPS, but was experimentally conrmed to generate
a tetrapeptide,106 indicating exceptions of the co-linearity rule.
In a global view, mining for genes encoding NRPS or NRPS-
related enzymes has revealed a wide distribution of these
This journal is © The Royal Society of Chemistry 2016 Nat. Prod. Rep., 2016, 33, 988–1005 | 993
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pathways in Bacteria and Eukarya. In a comprehensive study by
Wang et al.107 more than 3300 BGCs coding for more than
16 500 NRPS(like) enzymes have been identied. Interestingly,
a signicant number of the in silico identied enzymes do not
follow the classical modular organization of NRPSs. Only few of
these pathways have currently been studied experimentally, for
example the pathway for congocidin biosynthesis.81 This makes
it very challenging to interpret these BGCs and develop bio-
informatics algorithms to predict their products.
3.4 Ribosomally synthesized and post-translationally
modied peptides (RiPPs)
Lanthipeptide/lantibiotics have also been subject to successful
genome mining approaches. One of the rst examples, where
the identication of the biosynthetic gene cluster preceded the
discovery of the compound is lichenicidin.108 Begley et al. used
PSI-BLAST to mine publicly available microbial genome
sequences for homologues of the LanM lanthipeptide dehy-
dratase/cyclase, which catalyzes the dehydration and cyclization
of the lanthipeptide prepeptide using the sequence of LtnM1
involved in lacticin 3147 biosynthesis as query. Using this
strategy, they were able to identify 89 strains. 61 of these strains
were not previously described as lanthipeptide producers.
Among these hits was Bacillus licheniformis ATCC 14580, which
inhibited growth of Gram-positive bacteria, including L. mono-
cytogenes, methicillin resistant S. aureus and vancomycin
resistant enterococci. Indeed a lanthipeptide named lichen-
icidin, which had the predicted molecular weight could be
identied with mass spectrometry, isolated and re-tested
demonstrating that it caused the antibacterial eﬀect.
Another interesting example is the lanthipeptide ven-
ezuelin.109 When analyzing the dra genome sequence of S.
venezuelae, a novel type of lanthionine cyclase/dehydratase
named VenL was identied, which was composed of an N-
terminal serin/threonine kinase instead of the dehydratase
present in LanM/type II lanthipeptide biosynthesis pathways,
and a C-terminal LanC domain. Although it was not possible to
isolate a lanthipeptide from S. venezuelae, the authors were able
to express and purify VenL in E. coli and demonstrate its activity
as lanthionine synthase in vitro using synthesized
peptides.109,110 Using the datasets of Doroghazi et al.,111 only
recently it was possible to identify further Streptomyces strains
that possess BGCs that are similar to the venezuelin gene
cluster.112 HPLC-MS analyses indicated, that some of these
strains indeed produce venezuelin or closely related derivatives.
The latest member of the venezuelin family of lanthipeptides is
streptocollin, which was identied via antiSMASH-based
genome mining of S. collinus Tu¨ 365.113,114 This strain only
produces traces of streptocollin under the tested laboratory
conditions. However, by expressing the streptocollin biosyn-
thesis genes under control of a constitutive promoter in S. col-
linus Tu¨ 365 or by heterologously expressing the gene cluster in
the optimized expression host S. coelicolor M1152,115 prepara-
tive amounts of streptocollin could be obtained. While no
signicant antibacterial or antiviral activity was detected for
streptocollin, a moderate inhibitory activity towards protein-
tyrosine-phosphatase 1B, a potential target to treat type 2 dia-
betes or obesity, was observed.113
Similar to NRPs, the combination of genome mining with
computational mass spectrometry approaches provides valu-
able tools for the identication of novel compounds.103,116 One
of the rst peptides identied with this method was the type III
lanthipeptide informatipeptin produced by Streptomyces vir-
idochromogenes DSM 40736.116
Lasso peptides are another very interesting family of RiPPs
where genome mining has contributed much knowledge. Like
most RiPPs, biosynthesis of lasso peptides starts with the
ribosomal synthesis of a precursor peptide (A-peptide). This
precursor is post-translationally modied by an ATP-dependent
cysteine protease (B-protein), which cleaves-oﬀ the leader
peptide, and an ATP-dependent asparagine synthetase B-like
protein (C-protein), which catalyzes the lactam formation
between the N-terminal amino group and the side chain of an
aspartate or glutamate residue in the peptide leading to
a cyclized molecule. The latter reaction is catalyzed in a way
such that the C-terminal peptide tail is placed inside the ring
thus leading to the name-giving lasso structure. This structure
is usually stabilized by bulky plug residues of the peptide tail
that prevent the slip-out and disulde bonds that stabilize the
structure.117
The rst gene cluster of a lasso peptide wasmicrocin J25 of E.
coli AY25,118–120 where it was demonstrated that the precursor
peptide along with the genes mcjB and mcjC, which code for the
B- and C-proteins respectively, are responsible for microcin J25
biosynthesis. In addition, the microcin J25 gene cluster
contains mcjD, which codes for an ABC transporter that is
involved in conferring immunity. In the rst genome mining
study that targeted novel lasso peptides, the sequences of McjB,
McjC and McjD were used as in silico probes to mine genomic
databases. Knappe et al.121 were able to detect genes coding for
homologous enzymes in the genome sequence of Burkholderia
thailandensis E264. In a manual reinvestigation of the DNA
sequence upstream of the identied homologs the authors
could identify an un-annotated open reading frame that was
proposed to encode the precursor peptide. Indeed, the authors
were successful in detecting traces of the predicted lasso
peptide, named capistruin, in culture extracts of the strain. By
optimizing the fermentation media and purication procedure,
it was possible to obtain capistruin yields of 0.7 mg L1, which
provided suﬃcient amounts to conrm the structure of cap-
istruin via NMR-based methods. Finally, it was possible to clone
the capistruin BGC comprising of capABCD and express the
pathway in E. coli with yields of 0.2 mg L1, which is 30% of
the B. thailandensis wild type yield.121 In the meantime, many
additional lasso peptide biosynthetic gene clusters have been
identied by genomemining (Table 1). Similar approaches have
also been carried out for other classes of RiPPs, for example
thiazole/oxazole modied microcins (TOMMs).112
3.5 Terpenoids/isoprenoids
With almost 400 distinct structural families comprising in total
more than 55.000 described compounds, terpenoid/isoprenoid
994 | Nat. Prod. Rep., 2016, 33, 988–1005 This journal is © The Royal Society of Chemistry 2016
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secondary metabolites are one of the largest class of bioactive
metabolites, many produced by plants, fungi and also
bacteria.122 The core units of terpenoids are assembled from
a varying number of linked isoprene units (catalyzed by terpene
synthases) that can undergo a multitude of intramolecular
cyclizations, catalyzed by terpene cyclases, oen followed by
extensive tailoring steps. Although terpene synthases/cyclases
are oen not as highly conserved as, for example, NRPS or PKS it
is possible to use individual characterized sequences as probes.
Using these strategies, a variety of isoprenoids have been rstly
identied and characterized by genome mining, e.g., the
monoterpene cineolole,123 the diterpene cembrane,124 or the
sesterterpene stellatic acid.125
To cover a wide sequence space and to identify more
distantly related enzymes, a prole-HMM-based approach, that
uses HMM-proles trained with 140 bacterial terpene syn-
thases, was also successfully used to screen novel pathways and
identify a diverse set of new terpenoids.126,127
3.6 Screening for tailoring enzymes
Currently, most genome mining approaches focus on identi-
fying core biosynthetic enzymes in genomic or metagenomic
data.128 However, also so-called tailoring enzymes, that are
involved in modifying precursor molecules, can be valuable
targets to identify new BGCs. Already in the pre-genome mining
era, reverse genetics approaches have been carried out to
identify, for example, pathways encoding halogenases.129
With the availability of whole genome sequences, this
strategy has expanded in silico. For example, sequences of
bacterial desaturases/acetylenases were used as genomemining
probes to identify biosynthetic gene clusters synthesizing
compounds containing very rarely found alkyne groups.130,131
Other examples are the identication of BGCs encoding the
biosynthesis of epoxyketone biosynthetic pathways in meta-
genomic datasets that led to the discovery of the clarepoxcins
and landepoxcins, potent 20S proteasome inhibitors.132
4. Comparative genome mining
“Classical” genome mining, i.e. the specic search for genes
encoding enzymes involved in the biosynthesis of secondary
metabolites in (meta)genomic sequences, and sophisticated
soware aiding the scientists for this task, were one of the main
innovations within the history of natural products research in the
recent years.64,133 The method can be further rened by not only
focusing on single genes, but on partial or complete gene clus-
ters. This functionality is, for example, included in the soware
antiSMASH,78 which can compare the identied BGCs in user-
submitted genomes with a huge collection of BGCs of other
microorganisms and the curated MIBiG database,47 and thus
indicate whether there are similar pathways in other organisms.
The MultiGeneBlast algorithm, that provides such information,
is also available as a stand-alone soware,134which can be used to
identify similar gene clusters/operons for any given sequence.
Another approach to assess novelty of identied BGCs is to
use Genome Neighborhood Networks (GNNs),135 which are
extended variants of sequence similarity networks136 (Fig. 2) that
also take into account the neighborhood of the “target” gene.
Such a study has recently been carried out to comprehensively
study enediyne biosynthetic pathways and provide means for in
silico prioritization.137
Although targeted genome mining approaches are very
powerful and have led to the identication of new compounds
and associations between biosynthetic pathways and molecules,
they have one important limitation. As this approach requires
sequences of known homologous enzymes or explicitly dened
rules on what is considered a BGC, the results are limited to
known biosynthetic types and families. Oen, a diﬃcult task is to
connect new structural classes of compounds to their respective
BGCs. Once the BGC and biochemistry is identied, homologous
clusters and corresponding compounds can be detected in other
organisms as well. A powerful example for this is the patellamide
family of compounds.138 These highly modied cyclic peptides
have been isolated from the marine ascidian Lissoclinum patella
and were shown to be produced by cyanobacterial symbionts.139
Due to their highly modied amino acids, they were suspected to
be produced by an NRPS dependentmachinery for a long time. In
contrast, Schmidt and colleagues were able to link the production
to a class of ribosomal pathways140 later called cyanobactins that
added to the great variety of RiPP pathways and led to the
discovery of many more related molecules.141–143 Similarly, the
microviridin BGCs have been discovered.56 These tricyclic
peptides are biosynthesized by previously unknown classes of
ATP grasp domain containing enzymes,56,144,145which were shown
to be wide spread within free-living cyanobacteria.146,147
Fig. 2 Network of known BGCs from the MIBiG database47 using Pfam
composition similarity. Distances were calculated with an adapted
Jaccard and domain duplication index149 with a threshold of 0.5 and
clustered in Gephi156 using the Yifan Hu method.157 Colored regions
depict gene cluster type with examples of known compounds circled
based on MIBiG annotations.
This journal is © The Royal Society of Chemistry 2016 Nat. Prod. Rep., 2016, 33, 988–1005 | 995
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One approach to nd unknown types of biosynthetic gene
clusters more systematically was recently reported by Takeda
et al.148 The algorithm used to identify BGCs in lamentous
fungi is based on identifying homologous and orthologous
genes in related species, and evaluate syntenic and non-syn-
tenic regions. Unfortunately, the implementation of the algo-
rithm or a web server is not yet publicly available.
Another strategy was developed by Cimermancic et al.149 The
ClusterFinder algorithm uses a two-state hidden Markov model
trained on strings of contiguous Pfam domains identied in 677
validated gene clusters (BGC state) and strings of Pfam domains
of random genome regions (non-BGC state). This probabilistic
model then was used to screen 1154 prokaryotic genomes,
leading to the identication of more than 33 000 putative BGCs,
10 700 of the hits with high condence scores. The most
abundant class of biosynthetic gene clusters identied in this
study were saccharides, which comprised 40% of all hits. This
was unexpected as this class of molecules is only represented
with 13% of the validated test data set and thus indicates a huge
potential for nding new molecules. A global similarity analysis
of the high-condence hits revealed several “cliques”/families
of BGC that have not yet experimentally studied so far. Experi-
mental studies on selected members of this family (comprising
811 BGCs) revealed that one family codes for the biosynthesis of
aryl polyene lipids.149 ClusterFinder was also used in a study
analyzing data from the Human Microbiome Consortium.150 In
the human microbiome, saccharide and RiPP gene clusters
were also observed frequently, whereas NRPS and PKS gene
clusters were signicantly depleted.151 Based on these data,
Donia et al. were able to identify a novel thiopeptide (RiPP)
lactocillin, associate it with the corresponding BGC, and
demonstrate that the biosynthesis pathway is actually tran-
scribed in the human body.150
In a large-scale genome mining approach for type I and II
polyketides, NRPS, NRPS-independent siderophores, lanthi-
peptides and TOMMs in more than 800 actinobacterial
genomes Doroghazi et al.152 were able to identify more than
11 000 gene clusters which could be grouped into 4122 gene
cluster families (GCFs). The GCF network was calculated based
on the combination of three distance metrics on the number of
shared homologous genes, the proportion of nucleotides
involved in pairwise alignment and the amino acid sequence
identity of domains of modular enzymes. 77 of these GCFs
included at least one already known and characterized gene
cluster. Based on these, the authors identied 1193 uncharac-
terized gene clusters in a subset of 344 genomes, which likely
code for the biosynthesis of novel derivatives of known
compounds. The GCF network then was correlated with large-
scale high-resolution liquid chromatography/mass-spectrom-
etry data of a subset of 178 strains allowing the link between
metabolites and gene clusters.152 These datasets now are
a valuable source for further studies, such as a global analysis of
lanthipeptide biosynthetic pathways112 (see above).
These and other recent examples nicely demonstrate that
especially combining genome mining with metabolomics/chem-
informatics approaches, i.e. the automatic evaluation of mass
spectrometric data using peptide- or glycogenomics,29,30molecular
networking,100 self-organizing metabolomic maps,153 or compre-
hensiveMS/MS fragment databases, provide very powerful tools to
identify novel secondary metabolites.32,102,103,116,154,155
5. Phylogeny based mining methods
The idea of comparing multiple bacterial genomes to detect and
prioritize gene clusters is strongly connected to the idea of using
phylogenetic methods to nd promising secondary metabolite
genes. As Dobzhansky stated: “Nothing in biology makes sense
except in the light of evolution”.184 Understanding how nature
creates the amazing structural diversity of chemicals observed
and appreciated by natural product chemists is not just a basic
research question, but gives important insights into bio-
prospecting eﬀorts, ecological function of these molecules and
synthetic biology approaches.
The oen modular structure of secondary metabolite gene
clusters rendered the idea of a rapidly evolving defence system
that develops new molecules by randomly shuﬄing and swap-
ping domains and modules and develops analogous to an
adaptive immune system.185 The rst phylogenetic studies with
selected PKS and NRPS systems clearly showed signicant
amounts of homologous recombination and gene duplica-
tion.186–189 Most of these studies, however, are limited case
studies that include only a few related gene clusters that code
for very similar molecules. The limited amount of data available
at the time and the intensive computational demands on
phylogenetic algorithms impeded more systematical analysis.
With the diversity of tools for genome mining available now,
more systematic approaches to infer the evolutionary history of
nature's chemistry are available. One recent analysis of the
evolution of about 10 000 biosynthetic gene clusters revealed
signicantly higher rates of insertions, deletions and duplica-
tions in secondary metabolism compared to primary metabo-
lism and demonstrated how successful nature mixes and
matches sub-clusters to produce novel chemistry.190
Evolution and phylogenetic approaches have been used to
guide genome mining eﬀorts for a couple of years now. Two
major approaches can be distinguished in natural product
research.191,192 One uses species trees of natural product
producing organisms based on conserved housekeeping genes or
core genomes, andmaps compound production subsequently on
the tree. This way, talented chemistry producing lineages can be
traced to develop more eﬃcient sampling, isolation and genome
mining techniques.193 The genome mining of 75 closely related
Salinispora strains for example revealed major diﬀerences in the
metabolic diversity of the three distinct species within the genus,
proving S. pacica as the most diverse compared to its sister taxa
S. tropica and S. arenicola.194 In contrast, another study that
compared secondary metabolite gene cluster diversity within the
Streptomyces species S. pratensis revealed no diﬀerences in
natural product BGCs, even when isolated from various distant
geographic locations.195 An improved understanding of these
phylogenetic patterns can guide bioprospecting eﬀorts, especially
in combination with the discovery of new families and clades
within bacteria through directed cultivation eﬀorts51 or meta-
genomic sequencing.196
996 | Nat. Prod. Rep., 2016, 33, 988–1005 This journal is © The Royal Society of Chemistry 2016
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However, species patterns and taxonomical correlations have
to be interpreted carefully considering the tremendous amount
of horizontal gene transfer, which proves to play a vital role in
the evolution of secondary metabolites.189,190,194,197 A second
approach uses gene trees of secondary metabolite genes
directly. These gene trees infer the evolutionary history of
biosynthetic genes and gene clusters, and can oen be used to
infer biosynthetic functions of the enzymes more precisely than
simple sequence similarity approaches.198,199
For more in depth information about evolution and the use
of phylogenetic methods of natural products, we refer to other
reviews.191,192 Here we focus on examples of phylogeny based
mining techniques. Ketosynthase (KS) domains in PKS gene
clusters have been one of the rst enzyme families where
phylogenetic trees have been used to predict structures. Instead
of sequencing full genomes, at a time when this was not even yet
feasible, degenerated primers were constructed and amplied
PCR products sequenced.186,200,201 Based on the phylogeny of
these short sequence tags compound families and structures
could be predicted. If characterized known KS domains claded
closely with amplied PCR products, lineages without any
known characterized KS domain indicated unknown or novel
chemistry.
This concept was further developed by the Natural Product
Domain Seeker (NaPDoS), a bioinformatic pipeline that allows
the automated detection of KS and C domains from NRPS and
PKS gene clusters and subsequently constructs a phylogenetic
tree to infer novelty and potential of secondary metabolites from
bacterial genetic data.27 NaPDoS works for PCR products but also
dra and full bacterial genomes as well as assembled meta-
genomic data sets (http://napdos.ucsd.edu). The sequence tag
approach is especially useful for screening complex environ-
mental data such as soil and sediments, where complete gene
cluster assemblies are still challenging using recent sequencing
technologies, and can be used to infer diversity and genetic
potential of natural products in specic environments.132,202–204
Brady and colleagues developed the webtool esNAPD37 and phy-
logeo, a specialized R package38 to facilitate richness and diversity
analysis of NRPS and PKS sequence tags in soil and direct the
discovery of bioactive natural products from metagenomes as
shown for a novel pentangular polyphenol type II polyketide.94
This general concept of phylogeny of sequence tags as a guide for
secondarymetabolite genomemining was also expanded to other
enzyme families such as the chromopyrrolic acid synthase
responsible for the biosynthesis of rare tryptophan dimers205,206
and the epoxyketone family of compounds.132,173
A completely new aspect of using phylogeny and evolutionary
distances for genome mining purposes has been recently
developed by Barona-Gomez and colleagues.33 Their EvoMining
approach is based on the concept that enzymes involved in
secondary metabolism evolved by duplication and subsequent
expansion of substrate specicity of primary enzymes and these
expanded and repurposed enzyme families are detectable with
phylogenetic methods. They developed a genome mining
pipeline that detects homologues of certain classes of house-
keeping genes and compared the average number and phylo-
genetic distance of each enzyme family.
As proof of principle two previously uncharacterized
enzymes could be identied, an argininosuccinate lyase
involved in the biosynthesis of leupeptin and an unusual AroA
family enzyme involved in the biosynthesis of a putative novel
arseno-organic compound. Both compounds in this case have
been linked to known biosynthetic machineries such as NRPS
and PKS based systems. However, this approach has not only
the potential to detect novel highly unusual and previously
uncharacterized enzyme families but could be useful to detect
non-canonical secondary metabolic pathways, where no known
machinery has been previously described.
6. Resistance/target based mining
methods
Methods and tools to detect and extract secondary metabolite
gene clusters are nowadays quite well established, and with all
the microbial genomes available the biggest database at this
point, the JGI IMG-ABC database, contains more than 960 000
detected gene clusters,46 the majority are orphan. Analysing and
characterizing each and every one of these orphan gene clusters
in real wet-lab experiments is clearly not feasible. The challenge
is now to prioritize and focus on the most promising gene
clusters and gene cluster families. Which of the gene clusters is
most interesting certainly depends on what exactly researchers
are looking for and ranges from novel biosynthetic mecha-
nisms, novel structures or derivatives of compounds to new
bioactivities and modes of actions. However, predicting bioac-
tivities and mechanisms of actions in silico remains one of the
challenges of computational methods in drug discovery.
Resistance based and target based mining techniques are
relatively recently developed genome mining approaches that
aim to detect secondary metabolite gene clusters based on the
self-resistant mechanisms of an antibiotic producing organism.
The idea is based on the experience that BGCs not only contain
the biochemical enzymes for compound production, but also
encode additional important information such as regulatory
elements, transporter proteins and resistance mechanisms. A
bacterium that produces an antibiotic compound needs to
develop self-resistant mechanisms in order to avoid suicide.207
The resistant mechanisms vary and include eﬄux pumps,
degrading enzymes to remove toxic compounds, and modied
target proteins to prevent binding of antibiotics to the active site
of their targets.208 The gene clusters responsible for the
biosynthesis of the antibiotics novobiocin,209 platensin210 and
griselimycins211 are some examples were second copies of
resistant housekeeping genes (gyrB, fabB/F and dnaN respec-
tively) are directly encoded within the gene cluster.
The rst proof of principle that resistance can be used as
a discriminating criterion in antibiotic producing organisms
has been published in 2013. Wright and co-authors were able to
show that organisms resistant to glycopeptide and ansamycin-
like antibiotics are more likely to produce similar chemical
compounds,212 and an antibiotic resistance based discovery
platform was developed for the isolation of scaﬀold-specic
antibacterial producers.213 Moore and colleagues took this
This journal is © The Royal Society of Chemistry 2016 Nat. Prod. Rep., 2016, 33, 988–1005 | 997
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approach one step further and developed a target-directed
genome mining approach.35 By screening 86 highly related
strains of the marine actinomycete genus Salinispora for second
copies of house keeping genes and relating those to their
presence in biosynthetic gene clusters, they were able to identify
a duplicated bacterial fatty acid synthase in the direct vicinity of
an non-canonical hybrid PKS–NRPS gene cluster. Using direct
cloning, heterologous expression and mutational analysis, the
gene cluster was linked to the biosynthesis of thiolactomycin,
a known fatty acid synthase inhibitor. Thus, correlating putative
resistance genes with orphan secondary metabolite gene clus-
ters can be one way to mine bacterial genomes specically for
antibacterial compounds, at least in those cases, where resis-
tance is mediated by target modication.
With the rise of antibiotic resistant pathogens and the
urgent need for new antibiotics with novel mode of actions,
resistance-based genome mining techniques will be an impor-
tant toolkit for the discovery of specically antibacterial
compounds and mechanism of action studies in the future.
Well-curated databases of resistance genes such as CARD34 and
ARDB214 will play an important part in these eﬀorts. A recent
example for an automated online tool that can connect genomic
data, chemical structures and resistance genes is PRISM.215
Originally created to connect structural information and BGCs
in a high throughput fashion, a resistance-determinant library
of known antibiotic resistance has been added in order to
enable the targeted search for compounds with uncommon
modes of action.104 As proof of principle Johnston and
colleagues investigated the telomycin family of natural products
and identied a new mode of action for these compounds
binding to the phospholipid cardiolipin.
7. Mining for regulators
Understanding the complex regulation of secondary metabo-
lites in bacteria has been an important part of in the history of
genetics of secondary metabolites.216 Especially aer whole
genome sequences unveiled the large amount of silent gene
clusters not active under normal laboratory conditions,
researchers are looking for eﬀective ways to activate and opti-
mize production of encoded compounds. Specically bacteria
of the genus Streptomyces have been extensively studied for their
complex regulatory networks involved in secondary metabo-
lism.216–218 Global and pathway specic regulators,216,218 precur-
sors from primary metabolism,219 and small molecules220,221
includingN-acetylglucosamine222 have been shown to play a role
in regulation of natural products biosynthesis. Various tools
and databases have been developed to predict regulatory
elements in bacterial genomes and facilitate drug discovery and
compound optimization.223,224
One of the best-known systems of globally regulated
secondary metabolites present in a wide range of bacteria are
metal–chelating agents, including the well known iron binding
siderophore compounds.225 Siderophores are produced when
iron is limited to solubilize and facilitate the uptake of iron into
the cells. Other metal chelators are able to bind zinc or copper,
respectively.226 Involved in production regulation of these
metal–chelating compounds are two large families of global
regulators, the Fur and the IdeR family of transcriptional
repressors.227,228 If enough of the respective trace metal is
present in the cell, the repressor–metal complex binds
upstream of the BGC and silences transcription and production
of chelators. If metal concentration in the cytoplasm drops, the
metal–regulator complex disintegrates and is no longer able to
bind DNA, and production of compounds are activated. Using
this knowledge Stegmann and colleagues recently developed
a method called INBEKT (Identication of Natural compound
Biosynthesis pathways by Exploiting Knowledge of Transcrip-
tional regulation) to mine the genome of Amycolatopsis japoni-
cum MG417-CF17 for the BGC for ethylenediamine-disuccinate
(EDDS).36 EDDS is a biodegradable zinc–chelating alternative
for the widely industrially applied ethylenediamine-tetraacetate
(EDTA). No biosynthetic genes could be detected for EDDS
using canonical genome mining tools. However, screening the
genome of Amycolatopsis japonicum for zinc-binding regions led
to the identication and characterization of the aes genes
responsible for EDDS production. Considering that certain
classes of regulators are more oen connected to secondary
metabolites than others, this approach could be further devel-
oped in the future to mine genomes for non-canonical
secondary metabolite pathways.
Consideration of regulators is also an important technique
to study fungal secondary metabolite biosynthetic gene clusters.
Many fungal gene clusters encode cluster-specic regulators,
which result in activation of the gene cluster when articially
overexpressed.167 As the regulator binding sites are oen highly
conserved, they can be used to identify genes belonging to
fungal gene clusters by computational methods, such as
implemented in the soware CASSIS.229 Especially in fungi,
genes belonging to the same biosynthetic gene cluster are
highly co-regulated. Thus integrating transcriptomics data into
the genome mining workows can provide additional means to
identify BGCs and dene gene cluster borders.230–232 While the
rst approaches to integrate such data have involved many
manual steps, recently easy-to-use web-based implementations
of this approach have become available.233
8. Culture independent mining: single
cells and metagenomes
The amount and complexity of metagenomic data makes
mining them for secondary metabolites a specically chal-
lenging task. Especially large and highly repetitive gene clusters
such as NRPS and PKS pathways are rarely fully assembled.
However mining environmental DNA for natural products
opens the possibility to explore the large microbial world
present that is not yet cultured and study diversity and distri-
bution of these compounds directly in their environment.
Heterologous expression and synthetic biology approaches
allow subsequent capturing of sequenced pathways and enable
compound discovery.94,234 During the last decade assembly
problems were bypassed by sequence tag approaches and
phylogenetic classication to dereplicate and identify
998 | Nat. Prod. Rep., 2016, 33, 988–1005 This journal is © The Royal Society of Chemistry 2016
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promising novel biosynthetic gene clusters. Brady and
colleagues used sequence tag approaches to discover new
compounds directly from soil DNA,94,132,206 a diverse environ-
ment full of yet uncultured bacterial diversity and hidden
natural product potential.51,202,203
How much potential the so-called microbial dark matter
really contains in terms of chemistry and novel biosynthetic
machineries, has been demonstrated by genome mining
studies from obligate symbiotic bacteria of ascidians and
sponges.140 Schmidt and colleagues were able to identify the
biosynthetic machinery of the patellamides by screening fosmid
libraries from enriched Prochloron DNA, the cyanobacterial
symbiont of the ascidian Lissoclinum patella. Heterologous
production in E. coli proved a highly unusual RiPP pathway was
responsible for the biosynthesis of these cyclic peptides
(chapter 4). Sequencing the microbiome of further ascidians
and bryozoans allowed the assembly of genome sequences of
symbiotic proteobacteria, led to the identication of the patel-
lazole and bryostatin gene clusters, and showed the important
role of secondary metabolites in these organisms.235-237
A combination of metagenomic sequencing and single cell
genomics of a sponge microbiome recently revealed a whole
new candidate phylum ‘Tectomicrobia’ widely distributed in
sponges.196 Two diﬀerent genomes of the candidate genus
‘Entotheonella’ were assembled with genomes larger than 9
megabases and multiple biosynthetic gene clusters including
the highly unusual polytheonamide pathway.238
With sequencing cost constantly falling and improving read
length from technologies such as PacBio239 and Nanopore,240
assembly and mining of single cells and complex environments
will be easier in the future and help to uncover more of the
microbial dark matter and the enormous amounts of cryptic
gene clusters in unusual environments such as the human
microbiome.150
9. Conclusions
Enabled by the fast development of genome sequencing tech-
nologies, genome mining techniques rapidly evolved during the
last decade and are currently an important part of drug discovery
eﬀorts. Depending on focus and interest of researchers, diﬀerent
mining techniques and approaches have been developed to
detect, dereplicate and prioritize secondary metabolite gene
clusters. The sheer amount of data available is, and will be
challenging in the future, and will drive the constant develop-
ment of eﬀective computational tools and algorithms to guide
wet lab experiments. Sequencing of uncultured organisms and
whole environments, hand in hand with the improvements in
“omics” technologies, systems biology approaches and synthetic
biology will drive automated high-throughput analysis connect-
ing genomic, transcriptomic and metabolomic data to connect
genes more eﬃciently to molecules and vice versa (Fig. 3).
Furthermore, the possibilities of studying diversity and distri-
bution of secondary metabolites in their direct environment
provides the chance to learn more about the impact of these
compounds in their natural habitat. Fascinating examples of
complex symbiotic interactions of microbes and their environ-
ments regulated by small molecules and secondary metabolites
prove their important impact on shaping environmental niches.
A true understanding of natural products, their evolution and
role in the environment will give important insights in regula-
tion, distribution and mode of action studies and therefore
facilitate and maintain their use as human therapeutics.
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